Kacała, A.; Dorochowicz, M.; Patrzałek, D.; Janczak, D.; Guziński, M.
Safety and Feasibility of Transarterial Bleomycin–Lipiodol Embolization in Patients with Giant Hepatic Hemangiomas. Medicina 2023, 59, 1358.
https://doi.org/10.3390/medicina59081358
AMA Style
Kacała A, Dorochowicz M, Patrzałek D, Janczak D, Guziński M.
Safety and Feasibility of Transarterial Bleomycin–Lipiodol Embolization in Patients with Giant Hepatic Hemangiomas. Medicina. 2023; 59(8):1358.
https://doi.org/10.3390/medicina59081358
Chicago/Turabian Style
Kacała, Arkadiusz, Mateusz Dorochowicz, Dariusz Patrzałek, Dariusz Janczak, and Maciej Guziński.
2023. "Safety and Feasibility of Transarterial Bleomycin–Lipiodol Embolization in Patients with Giant Hepatic Hemangiomas" Medicina 59, no. 8: 1358.
https://doi.org/10.3390/medicina59081358
APA Style
Kacała, A., Dorochowicz, M., Patrzałek, D., Janczak, D., & Guziński, M.
(2023). Safety and Feasibility of Transarterial Bleomycin–Lipiodol Embolization in Patients with Giant Hepatic Hemangiomas. Medicina, 59(8), 1358.
https://doi.org/10.3390/medicina59081358